Related Experiment Video
Updated: Aug 23, 2025

04:14
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
12.1K
Nonalcoholic Steatohepatitis Diagnosis - A Model-Related Personalized Medicine Approach
1Inserm URMS 1142, Sorbonne University, Paris- France.
Studies in Health Technology and Informatics
|November 3, 2022
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is a clinical syndrome, and pathologically characterized by diffuse macro-vesicular fatty change in the hepatocytes. NAFLD includes simple nonalcoholic fatty liver disease, nonalcoholic steatohepatitis (NASH) and hepatic cirrhosis. NASH is a disease evolving under the influence of various stimuli still poorly understood, but where insulin resistance is prominently. In this paper, we present a new diagnosis model to predict NASH.

